国信（香港）基金周报：美对等关税战升级，港股预计受影响有限并冲击新高-20250714

Group 1: Market Overview - The report highlights that the escalation of the US tariff war is expected to have a limited impact on the Hong Kong stock market, which is projected to reach new highs [7] - The Hong Kong Hang Seng Index has shown a year-to-date increase of 20.34%, indicating strong market performance despite external pressures [2] - The report notes that the US stock market indices reached historical highs, reflecting a resilient risk appetite among investors [8] Group 2: Investment Opportunities - The biotechnology sector in Hong Kong is identified as a key driver of market recovery, with Chinese pharmaceutical companies transitioning from generic to innovative drug development [9] - The report suggests that the overall market capitalization of Chinese biotech companies is only 14%-15% of that in the US, while contributing nearly 33% to global innovation, indicating significant growth potential [9] - The report recommends focusing on the medical and stablecoin sectors within the Hong Kong market for potential investment opportunities [12] Group 3: Currency and Fund Performance - The US dollar index has shown a strong weekly performance, indicating a potential bottoming out, with expectations for the USD/CNY exchange rate to fluctuate between 7.1 and 7.4 [10] - The report lists several funds with notable performance, including the Huaxia Hang Seng Biotechnology Index ETF, which has a one-year return of 87.57% [14] - Investors are advised to consider dollar-denominated money market funds for stable returns amidst currency fluctuations [11]